Retour
18
Fourchette du Jour
69,93 €
72,05 €
Fourchette 52 Semaines
61,78 €
89,83 €
Volume
1 736 222
Moyenne 50J / 200J
80,00 €
/
74,62 €
Clôture Précédente
69,96 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 36,6 | 0,4 |
| P/B | 1,7 | 2,9 |
| ROE % | 4,6 | 3,7 |
| Net Margin % | 9,2 | 3,8 |
| Rev Growth 5Y % | 8,8 | 10,0 |
| D/E | 0,3 | 0,2 |
Points Clés
Revenue grew 8,78% annually over 5 years — modest growth
ROE of 4,59% is below average
Debt/Equity of 0,34 — conservative balance sheet
Generating 433,70M in free cash flow
P/E of 36,56 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,72%
Croissance
Revenue Growth (5Y)
8,78%
Revenue (1Y)5,06%
Earnings (1Y)-4,44%
FCF Growth (3Y)42,03%
Qualité
Return on Equity
4,59%
ROIC4,65%
Net Margin9,16%
Op. Margin16,69%
Sécurité
Debt / Equity
0,34
Current Ratio1,89
Interest Coverage6,83
Valorisation
P/E Ratio
36,56
P/B Ratio1,66
EV/EBITDA23,98
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,06% | Revenue Growth (3Y) | 6,72% |
| Earnings Growth (1Y) | -4,44% | Earnings Growth (3Y) | 12,89% |
| Revenue Growth (5Y) | 8,78% | Earnings Growth (5Y) | -40,27% |
| Profitability | |||
| Revenue (TTM) | 4,09B | Net Income (TTM) | 374,90M |
| ROE | 4,59% | ROA | 3,02% |
| Gross Margin | 60,67% | Operating Margin | 16,69% |
| Net Margin | 9,16% | Free Cash Flow (TTM) | 433,70M |
| ROIC | 4,65% | FCF Growth (3Y) | 42,03% |
| Safety | |||
| Debt / Equity | 0,34 | Current Ratio | 1,89 |
| Interest Coverage | 6,83 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 36,56 | P/B Ratio | 1,66 |
| P/S Ratio | 3,35 | PEG Ratio | -8,16 |
| EV/EBITDA | 23,98 | Dividend Yield | 0,00% |
| Market Cap | 13,70B | Enterprise Value | 16,38B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4,09B | 3,90B | 3,59B | 3,31B | 2,92B |
| Net Income | 374,90M | 392,30M | 294,20M | 385,80M | 2,94B |
| EPS (Diluted) | 1,87 | 1,96 | 1,48 | 1,94 | 59,07 |
| Gross Profit | 2,48B | 2,60B | 2,36B | 2,14B | 1,96B |
| Operating Income | 682,90M | 705,70M | 533,10M | 507,60M | 505,80M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12,39B | 12,32B | 11,66B | 11,49B | 9,61B |
| Total Liabilities | 4,16B | 4,23B | 4,11B | 4,32B | 2,66B |
| Shareholders' Equity | 8,24B | 8,08B | 7,55B | 7,17B | 6,94B |
| Total Debt | 2,78B | 2,58B | 2,57B | 2,76B | 1,48B |
| Cash & Equivalents | 110,60M | 107,60M | 120,80M | 138,20M | 95,90M |
| Current Assets | 2,11B | 1,95B | 1,70B | 1,53B | 1,47B |
| Current Liabilities | 1,11B | 1,02B | 969,00M | 1,28B | 732,10M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#975 of 1024
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026